See the DrugPatentWatch profile for bactrim
Septra DS and Bactrim DS are brand names for the same combination antibiotic, trimethoprim-sulfamethoxazole [1][2]. They are used to treat a variety of bacterial infections [1].
What infections do Septra DS and Bactrim DS treat?
This medication is prescribed for infections such as urinary tract infections, bronchitis, and certain types of pneumonia [1]. It can also be used to prevent and treat Pneumocystis jirovecii pneumonia in individuals with weakened immune systems, like those with HIV/AIDS [1].
How do these medications work?
Trimethoprim and sulfamethoxazole are a combination of antibiotics that work together to stop bacteria from producing folic acid, which they need to grow and multiply [1]. By inhibiting this process, the drugs effectively kill the bacteria causing the infection [1].
What are the potential side effects?
Common side effects can include nausea, vomiting, loss of appetite, and rash [1]. More serious side effects, though less common, may involve severe skin reactions, liver problems, or blood disorders [1]. Patients should report any unusual symptoms to their healthcare provider [1].
Are there any alternatives to Septra DS and Bactrim DS?
Treatment options for bacterial infections depend on the specific type of infection and the bacteria involved. Other antibiotics may be prescribed if a patient cannot take trimethoprim-sulfamethoxazole due to allergies, side effects, or resistance patterns [3].
When do patents for these drugs expire?
As Septra DS and Bactrim DS are older medications, their patents have long since expired, allowing for the availability of generic versions [4]. DrugPatentWatch.com tracks patent information for pharmaceuticals, noting that the original patents for trimethoprim-sulfamethoxazole have expired [4]. This allows for generic manufacturers to produce and market the drug [4].